Invincible

Florence Comite is an endocrinologist specializing in hormones and metabolism. Drawing on decades of clinical practice and a research fellowship at the National Institutes of Health (NIH), she argues that chronic diseases associated with aging, including diabetes, heart disease, and dementia, are not inevitable. They can be predicted, detected, and reversed decades before symptoms emerge through personalized, proactive Precision Medicine.

The book opens with a formative moment. On the day Comite graduated from Yale University School of Medicine, her father asked what he could do to stay healthy as he aged. She had no answer because medical school trained her only to diagnose and treat existing disease. That question drove her career. She began connecting variables like glucose, insulin, cholesterol, hormones, and family history to detect disorders of aging in outwardly healthy patients as early as their twenties and thirties. Years later, her father experienced chest pain and fatigue while climbing subway stairs, leading to a cardiac catheterization that revealed narrowed coronary arteries. Comite argues this event could have been prevented through proactive detection. She introduces her method, called Nof1, which treats each patient as a clinical trial of one, tailoring interventions to the individual's unique genetics, biomarkers, habits, and family history. She identifies seven common patterns of aging and health decline into which she categorizes every patient, reporting striking practice-wide outcomes, including that zero heart attacks have occurred among patients continuously engaged in the program.

Part One establishes how aging works at the biological level. Comite explains that around age thirty, hormones, beginning with testosterone, decline in both men and women, reducing muscle mass and allowing fat accumulation that disrupts glucose metabolism and fosters inflammation. She presents eleven hallmarks of aging, including genomic instability (the accumulation of DNA damage and mutations that destabilize cells), telomere attrition (the shortening of protective chromosome caps), mitochondrial dysfunction (declining cellular energy production), cellular senescence (damaged "zombie cells" that secrete inflammatory molecules), and gut dysbiosis (intestinal microbial imbalance). These hallmarks are interconnected, and lifestyle behaviors can positively influence the epigenome, the chemical layer above DNA that turns genes on or off without altering the genetic sequence.

Comite argues that every human is biologically unique, making one-size-fits-all medicine inadequate. She draws on her experience as an identical twin and cites NASA's twin study of astronauts Mark and Scott Kelly to show that even people sharing the same genome differ due to epigenetic factors. She urges readers to become their own health advocates by gathering family health history and tracking lifestyle habits.

Two self-assessment tools anchor Part One. The first is the continuous glucose monitor (CGM), a small device attached to the arm that measures glucose in real time. Comite describes discovering that a banana spiked her blood sugar while a chocolate chip cookie did not, demonstrating that glucose responses are highly individual. She provides a four-week guide for first-time users and specifies that optimal fasting glucose should be 70 to 80 mg/dL. The second tool is a set of five blood tests she calls the Five Biomarkers of True Health: fasting glucose, hemoglobin A1c (average blood sugar over roughly 100 days), fasting insulin (which she considers the most significant early warning for diabetes), cholesterol risk ratio (total cholesterol divided by high-density lipoprotein, or HDL, sometimes called "good cholesterol"), and free testosterone. For each, she sets optimal thresholds stricter than conventional ranges, arguing that standard cutoffs miss early metabolic dysfunction.

Part Two describes seven aging patterns, each illustrated with patient cases and paired with interventions. Aging Pattern One, carbohydrate metabolism disorder, is the foundational pattern. Comite contends that virtually all humans are genetically predisposed to sugar metabolism disorders, a legacy of evolution's "thrifty gene" that stored fat for famine. She presents a patient whose insulin resistance, low testosterone, and underactive thyroid were reversed through thyroid medication, a CGM, and semaglutide (Ozempic), a GLP-1 receptor agonist. GLP-1 receptor agonists are a class of drugs that mimic a gut hormone to lower blood sugar and suppress appetite. Interventions include prioritizing protein, choosing low-glycemic carbohydrates, and performing resistance exercise.

Aging Pattern Two addresses cardiovascular disease. Comite emphasizes that genetics accounts for one-third to one-half of heart disease risk and presents a patient who, after surviving a heart attack at fifty-seven, showed no remaining heart damage on MRI years later following testosterone optimization therapy. She recommends advanced diagnostics including apolipoprotein B (ApoB) testing, a blood marker of plaque-forming particles, and coronary CT angiograms.

Aging Pattern Three covers thyroid disorders, which Comite argues are vastly underdiagnosed because symptoms like weight gain and fatigue mimic normal aging and because standard thyroid-stimulating hormone (TSH) testing alone is insufficient. She presents patients with Hashimoto's thyroiditis, an autoimmune disease causing underactive thyroid, and Graves' disease, which causes thyroid overactivity.

Aging Pattern Four addresses perimenopause and menopause. Comite reframes these transitions as manageable, explaining the hormonal fluctuations of estrogen, declining progesterone, and falling testosterone that can drive weight gain and metabolic disruption. She confronts the legacy of the 2002 Women's Health Initiative (WHI) study, which linked hormone therapy to increased cancer risk, arguing that the study's design was flawed and that subsequent research found no increased long-term risk. Aging Pattern Five, periandropause and andropause, is the male counterpart. Comite coined the term "periandropause" to describe the gradual hormonal decline beginning around thirty in men. She explains that erectile dysfunction is often the earliest warning sign of cardiovascular disease and refutes the belief that testosterone therapy causes prostate cancer, citing large studies showing no increased risk.

Aging Pattern Six focuses on sarcopenia (age-related muscle loss) and osteopenia (bone density loss). Comite calls muscle the "fountain of youth," citing research showing that ninety minutes of weekly strength training produced telomere lengths indicative of a biological age nearly four years younger. Aging Pattern Seven addresses brain fog, memory loss, and dementia. Comite links cognitive decline to metabolic health, noting that up to 81 percent of Alzheimer's patients also have diabetes or insulin resistance. She discusses the APOE4 gene variant, the most studied genetic risk factor for late-onset Alzheimer's, and presents a patient whose sudden memory loss was traced to neurotoxic pesticide exposure compounded by a genetic variant impairing B vitamin absorption. High-dose methylated B12, folate, and antioxidants resolved his symptoms within two months. She also discusses promising therapies including FDA-approved monoclonal antibodies targeting amyloid plaques.

Part Three provides programs for extending healthspan. The sleep chapter argues that sleep surpasses diet and exercise as a health lever, explaining the brain's glymphatic system, which clears toxic waste including beta-amyloid during deep sleep. Comite provides strategies including morning light exposure, caffeine cutoffs, cool and dark sleeping environments, and natural aids like magnesium L-threonate. The nutrition chapter contends that no single diet works for everyone, advocating CGM-guided eating: starting meals with protein, choosing healthy fats, and consuming 25 to 30 grams of fiber daily. She recommends supplements including methylated B vitamins, coenzyme Q10 (CoQ10, a compound involved in cellular energy production), omega-3 fatty acids, and vitamin D with K2. The fitness chapter presents evidence that strength training reverses biological aging, offers pattern-specific workout programs, and introduces "exercise snacks," brief intense bursts of activity throughout the day.

The final chapter covers GLP-1 receptor agonists, including semaglutide (Ozempic) and tirzepatide (Mounjaro), a dual agonist that also targets glucose-dependent insulinotropic polypeptide (GIP), a gut hormone involved in blood sugar regulation. Comite argues these drugs can extend healthspan but must be paired with strength training, adequate protein, and hormone optimization to prevent muscle loss. She describes research applications beyond diabetes, including cardiovascular protection, neuroprotection, cancer risk reduction, and addiction management.

In the afterword, Comite returns to her father's question about staying healthy for life and declares that she now has the answer. She frames the current moment as a medical revolution accelerated by AI and GLP-1 medications and distills the book's thesis into three directives: start where you are, measure what matters, and personalize the plan.